J.B. Chemicals & Pharmaceuticals announced significant leadership changes effective in early March 2026. Three senior management personnel have resigned, with their last working days staggered between March 5th and March 6th. The departing executives include the President of Operations, the President (India Business), and the Executive Vice President. The company has assured stakeholders that letters of resignation have been received and that a seamless transition will be managed.
Disclosure of Senior Management Changes
J.B. Chemicals & Pharmaceuticals Limited issued a formal disclosure on March 10, 2026, regarding the resignation of three key members of its senior management team, pursuant to regulatory requirements.
Key Resignations and Last Working Days
The company confirmed the following cessations of employment:
- Mr. Kunal Khanna, President – Operations, ceased his role effective from the closing of business hours on March 5, 2026.
- Mr. Dilip Singh Rathore, President (India Business), also concluded his tenure effective March 5, 2026.
- Mr. Jason D’souza, Executive Vice President, resigned effective from the closing of business hours on March 6, 2026.
Transition Assurance
The attached resignation letters confirm that the individuals provided their notices in early February 2026. Mr. Kunal Khanna and Mr. Dilip Singh Rathore aligned their last day to March 5, 2026, while Mr. Jason D’souza indicated a desire to serve a 3-month notice period, although his effective cessation date was noted as March 6, 2026 in the primary announcement. The company stated it has received the formal letters tendering these resignations and is working to ensure a seamless transition of responsibilities.
The document was signed by Sandeep Phadnis, Vice President – Secretarial & Company Secretary, on behalf of J.B. Chemicals & Pharmaceuticals Limited.
Source: BSE
